Palliative thoracic radiotherapy for lung cancer

Expert Review of Anticancer Therapy

Volumn 10, Issue 4, 2010, Pages 559-569

  Kepka, Lucyna ^a   Olszyna Serementa, Marta ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

Endobronchial brachytherapy; Lung cancer; Palliative radiotherapy; Quality of life; Re irradiation

Indexed keywords

ANTINEOPLASTIC AGENT; ANTINEOPLASTIC METAL COMPLEX; CISPLATIN; ETOPOSIDE; GEMCITABINE; NAVELBINE;

BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; COUGHING; DYSPHAGIA; DYSPNEA; EXTERNAL BEAM RADIOTHERAPY; HEMOPTYSIS; HUMAN; INTERMETHOD COMPARISON; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; PALLIATIVE THERAPY; RADIATION DOSE; RADIATION DOSE FRACTIONATION; REVIEW; SUPERIOR CAVA VEIN SYNDROME; SYSTEMATIC REVIEW; THORAX PAIN; TREATMENT INDICATION;

ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; HUMANS; LUNG NEOPLASMS; PALLIATIVE CARE; RADIOTHERAPY DOSAGE; SMALL CELL LUNG CARCINOMA; SURVIVAL; TIME FACTORS; TREATMENT OUTCOME;

EID: 77951215311     PISSN: 14737140     EISSN: 17448328     Source Type: Journal    
DOI: 10.1586/era.10.22     Document Type: Review

References (69)

1. Hawson G, Zimmerman PV, Ford CA, Johnston NG, Firouz-Abadi A. Primary lung cancer: characterization and survival of 1024 patients treated in a single institution. Med. J. Aust. 152(5), 230-234 (1990). (Pubitemid 20120518)
2. Jassem J. The role of radiotherapy in lung cancer: where is the evidence? Radiother. Oncol. 83(2), 203-213 (2007). (Pubitemid 46776921)
3. Fairchild A, Harris K, Barnes E et al. Palliative thoracic radiotherapy for lung cancer: a systematic review. J. Clin. Oncol. 26(24), 4001-4011 (2008).
4. Budach W, Belka C. Palliative percutaneous radiotherapy in non-small-cell lung cancer. Lung Cancer 45(2), S239-S245 (2004). (Pubitemid 39488194)
5. Bezjak A, Dixon P, Brundage M et al. Randomized Phase III trial of single versus fractionated thoracic radiation in the palliation of patients with lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 54(3), 719-729 (2002).
6. Kramer GW, Wanders SL, Noordijk EM et al. Results of the Dutch national study of the palliative effect of irradiation using two different treatment schemes for non-small-cell lung cancer. J. Clin. Oncol. 23(13), 2962-2970 (2005).
7. Senkus-Konefka E, Dziadziuszko R, Bednaruk-Mlynski et al. A prospective randomised study to compare two palliative radiotherapy schedules for non-small cell lung cancer (NSCLC). Br. J. Cancer 92(6), 1038-1045 (2005). (Pubitemid 40546666)
8. Medical Research Council Lung Cancer Working Party. Inoperable non-small-cell lung cancer (NSCLC): a Medical Research Council (MRC) randomised trial of palliative radiotherapy with two fractions or ten fractions. Br. J. Cancer 63(2), 265-270 (1991).
9. Medical Research Council Lung Cancer Working Party. A Medical Research Council (MRC) randomised trial of palliative radiotherapy with two fractions or a single fraction in patients with inoperable non-small-cell lung cancer (NSCLC) and poor performance status. Br. J. Cancer 65(6), 934-941 (1992).
10. Medical Research Council Lung Cancer Working Party. Randomised trial of palliative two-fraction versus more intensive 13-fraction radiotherapy for patients with inoperable NSCLC and good performance status. Clin. Oncol. 8(3), 167-175 (1996). (Pubitemid 26248531)
11. Belderbos JS, Kepka L, Spring Kong F-M, Martel MK, Videtic GM, Jeremic B. Report from the International Atomic Energy Agency (IAEA) consultants' meeting on elective nodal irradiation in lung cancer: non-small cell lung cancer (NSCLC). Int. J. Radiat. Oncol. Biol. Phys. 72(2), 335-342 (2008).
12. Videtic GMM, Belderbos JSA, Spring Kong F-M, Kepka L, Martel MK, Jeremic B. Report from the International Atomic Energy Agency (IAEA) consultants' meeting on elective nodal irradiation in lung cancer: small cell lung cancer (SCLC). Int. J. Radiat. Oncol. Biol. Phys. 72(2) 327-334 (2008).
13. Rowell NP, Gleeson FV. Steroids, radiotherapy, chemotherapy and stents for superior vena caval obstruction in carcinoma of the bronchus: a systematic review. Clin. Oncol. (R. Coll. Radiol.) 14(5), 338-351 (2002)
14. Kepka L, Danilova V, Saghatelyan T et al. Resources and management strategies for the use of radiotherapy in the treatment of lung cancer in Central and Eastern European countries: results of an International Atomic Energy Agency (IAEA) survey. Lung Cancer 56(2), 235-245 (2007). (Pubitemid 46591989)
15. Miller RR, McGregor DH. Haemorrhage from carcinoma of the lung. Cancer 46(1), 200-205 (1980).
16. Langendijk JA, Tjwa MK, de Jong JM, ten Velde GP, Wouters EF, Massive haemoptysis after radiotherapy in inoperable non-small cell lung carcinoma: is endobronchial brachytherapy really a risk factor? Radiother. Oncol. 49(2), 175-183 (1998).
17. Gasinska A, Kolodziejski L, Niemiec J, Dyczek S. Clinical significance of biological differences between cavitated and solid forms of squamous cell lung cancer. Lung Cancer 49(2), 171-179 (2005). (Pubitemid 40966744)
18. NSCLC Meta-Analyses Collaborative Group. Chemotherapy in addition to supportive care improves survival in advanced non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data from 16 randomized controlled trials. J. Clin. Oncol. 26(28), 4617-4625 (2008).
19. Socinski MA, Crowell R, Hensing TE et al. Treatment of non-small cell lung cancer, stage IV. ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132(3 Suppl.), 277S-289S (2007). (Pubitemid 47502813)
20. Lester JF, Macbeth FR, Toy E, Coles B. Palliative radiotherapy regimens for non-small cell lung cancer. Cochrane Database Syst. Rev. 18(4), CD002143 (2006).
21. Nestle U, Nieder N, Walter K et al. A palliative accelerated irradiation regimen for advanced non-small cell lung cancer vs. conventionally fractionated 60 Gy: results of a randomized equivalence study. Int. J. Radiat. Oncol. Biol. Phys. 48(1), 95-103 (2000). (Pubitemid 30488218)
22. Sundstrom S, Bremnes R, Aasebo U et al. Hypofractionated palliative radiotherapy (17 Gy per 2 fractions) in advanced non-small cell lung carcinoma is comparable to standard fractionation for symptom control and survival: a national Phase III trial. J. Clin. Oncol. 22(5), 801-810 (2004). (Pubitemid 41103591)
23. Erridge SC, Gaze MN, Price A et al. Symptom control and quality of life in people with lung cancer: a randomised trial of two palliative radiotherapy fractionation schedules. Clin. Oncol. 17(1), 61-67 (2005). (Pubitemid 40090198)
24. Salvo N, Hadi S, Napolskikh J, Goh P, Sinclair E, Chow E. Quality of life measurement in cancer patients receiving palliative radiotherapy for symptomatic lung cancer. A literature review. Curr. Oncol. 16(2), 16-28 (2009).
25. Langendijk JA, ten Velde GP, Aaronson NK, de Jong JM, Muller MJ, Wouters EF. Quality of life after palliative radiotherapy in non-small cell lung cancer: a prospective study. Int. J. Radiat. Oncol. Biol. Phys. 47(1), 149-155 (2000). (Pubitemid 30181223)
26. Reinfuss M, Glinski B, Kowalska T et al. [Radiotherapy in stage III, unresectable, asymptomatic non-small cell lung cancer. Final results of a prospective randomized study of 240 patients]. Cancer Radiotherapie 3(6), 475-479 (1999).
27. Simpson JR, Francis ME, Perez-Tamayo R, Marks RD, Rao DV. Palliative radiotherapy for inoperable carcinoma of the lung: final report of a RTOG multi-institutional trial. Int. J. Radiat. Oncol. Biol. Phys. 11(4), 751-758 (1985). (Pubitemid 15086898)
28. Teo P, Tai TH, Choy D, Tsui KH. A randomized study on palliative radiation therapy for inoperable non small cell carcinoma of the lung. Int. J. Radiat. Oncol. Biol. Phys. 41(4), 867-871 (1988).
29. Abratt RP, Shepherd LJ, Salton DG. Palliative radiation for stage 3 non-small cell lung cancer - a prospective study of two moderately high dose regimens. Lung Cancer 13(2), 137-143 (1995).
30. Rees GJ, Devrell CE, Barley VL, Newman HF. Palliative radiotherapy for lung cancer; two versus five fractions. Clin. Oncol. 9(2), 90-95 (1997). (Pubitemid 27198976)
31. Christian E, Adamietz IA, Willach N et al. Radiotherapy in oncological emergencies - final results of a patterns of care study in Germany, Austria and Switzerland. Acta Oncol. 47(1), 81-89 (2008).
32. Temel JS, Jackson VA, Billings A et al. Phase II study: integrated palliative care in newly diagnosed advanced non-small cell lung cancer patients. J. Clin. Oncol. 25(17), 2377-2382 (2007). (Pubitemid 47007615)
33. Falk S, Girling D, White R et al. Immediate versus delayed palliative thoracic radiotherapy in patients with unresectable locally advanced non-small cell lung cancer and minimal thoracic symptoms: randomised controlled trial. Br. Med. J. 325(7362), 465-472 (2002).
34. Sundstrom S, Bremnes R, Brunswing P et al. Immediate or delayed radiotherapy in advanced non-small cell lung cancer (NSCLC)? Data from a prospective randomised study. Radiother. Oncol. 75(2), 141-148 (2005). (Pubitemid 40805242)
35. Cardona AF, Reveiz L, Ospina EG, Ospina V, Yepes A. Palliative endobronchial brachytherapy for non-small cell lung cancer. Cochrane Database Syst. Rev. 16(2) CD004284 (2008). (Pubitemid 351807393)
36. Ung Y, Yu E, Falkson C et al. The role of high-dose-rate brachytherapy in the palliation of symptoms in patients with non-small-cell lung cancer: a systematic review. Brachytherapy 5(3), 189-202 (2006). (Pubitemid 44088682)
37. Stout R, Barber P, Burt P et al. Clinical and quality of life outcomes in the first United Kingdom randomized trial of endobronchial brachytherapy (intraluminal radiotherapy) vs external beam radiotherapy in the palliative treatment of inoperable non-small cell lung cancer. Radiother. Oncol. 56 (3), 323-327 (2000).
38. Moghissi K, Bond MG, Sambrook RJ, Stephens RJ, Hopwood P, Girling DJ. Treatment of endotracheal or endobronchial obstruction by non-small cell lung cancer: lack of patients in an MRC randomized trial leaves key questions unanswered. Medical Research Council Lung Cancer Working Party. Clin. Oncol. 11(2), 79-83 (1999). (Pubitemid 29366590)
39. Huber RM, Fischer R., Hautmann H, Pollinger B, Haussinger K, Wendt T. Does additional brachytherapy improve the effect of external irradiation? A prospective, randomized study in central lung tumors. Int. J. Radiat. Oncol. Biol. Phys. 38(3), 533-540 (1997). (Pubitemid 27305014)
40. Langendijk H, de Jong J, Tjwa M et al. External irradiation versus external irradiation plus endobronchial brachytherapy in inoperable non-small cell lung cancer: a prospective randomized study. Radiother. Oncol. 58(3), 257-268 (2001). (Pubitemid 32181859)
41. Sharma SC, Behera D, Beriwal S et al. Evaluation of addition of endobronchial brachytherapy for symptoms relief in locally advanced bronchogenic carcinoma. A prospective randomized study. J. Clin. Radiother. Oncol. 2(1), 14-19 (2002).
42. Sur R, Donde B, Mohiuddin M et al. Randomized prospective study on the role of high dose rate intraluminal brachytherapy (HDRILBT) in palliation of symptoms in advanced non small cell lung cancer (NSCLC) treated with radiation alone. Int. J. Radiat. Oncol. Biol. Phys. 60(1 Suppl. 1), 127S (2004).
43. Villanueva AG, Lo TCM, Beamis JF. Endobronchial brachytherapy. Clin. Chest Med. 16(3), 445-454 (1995).
44. Escobar-Sacristan JA, Granda-Orive JI, Gutierrez Jimenez T, Delgado JM, Rodero Banos A, Saez Valls R. Endobronchial brachytherapy in the treatment of malignant lung tumours. Eur. Respir. J. 24(3), 348-352 (2004). (Pubitemid 39232253)
45. Skowronek J, Kubaszewska M, Kanikowski M, Chichel A, Mlynarczyk W. HDR endobronchial brachytherapy (HDRBT) in the management of advanced lung cancer - comparison of two different dose schedules. Radiother. Oncol. 93(3), 436-440 (2009).
46. Kaasa S, Thorud E, Host H, Lien HH, Lund E, Sjolie I. A randomized study evaluating radiotherapy versus chemotherapy in patients with inoperable non-small cell lung cancer. Radiother. Oncol. 11(1), 7-13 (1988). (Pubitemid 18033501)
47. Higgins MJ, Ettinger DS. Chemotherapy for lung cancer: the state of the art in 2009. Expert Rev. Anticancer Ther. 9(10), 1365-1378 (2009).
48. Shepherd FA, Dancey J, Ramlau R et al. Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy. J. Clin. Oncol. 18(10), 2095-2103 (2000). (Pubitemid 30324363)
49. Hanna N, Shepherd FA, Fosella FV et al. Randomized Phase III trial of pemetrexed versus docetaxel in patients with non-small cell lung cancer previously treated with chemotherapy. J. Clin. Oncol. 22(9), 1589-1597 (2004). (Pubitemid 41079796)
50. Jeremic B, Shibamoto Y, Milicic B et al. Short-term chemotherapy and palliative radiotherapy for elderly patients with stage IV non-small cell lung cancer: a Phase II study. Lung Cancer 24(1), 1-9 (1999). (Pubitemid 29241811)
51. Michael M, Wirth A, Ball DL et al. A Phase I trial of high-dose palliative radiotherapy plus concurrent weekly vinorelbine and cisplatin in patients with locally advanced and metastatic NSCLC. Br. J. Cancer 93(6), 652-661 (2005). (Pubitemid 41486456)
52. Nawrocki S, Rucinska M, Krzakowski M. Palliative chemoradiotherapy is superior to palliative radiotherapy in stage IIIA - IIIB non-small cell lung cancer patients not eligible for radical treatment - final results of randomized Phase II study. J. Thorac. Oncol. 4 (9 Suppl. 1), 702-703 (2009) (Abstract 1226).
53. Green N, Melbye RW. Lung cancer: retreatment of local recurrence after definitive irradiation. Cancer 49(5), 865-868 (1982). (Pubitemid 12184084)
54. Jackson MA, Ball DL. Palliative retreatment of locally-recurrent lung cancer after radical radiotherapy. Med. J. Aust. 147(8), 391-394 (1987).
55. Montebello JF, Aron BS, Manatunga AK, Horvath JL, Peyton FW. The reirradiation of recurrent bronchogenic carcinoma with external beam irradiation. Am. J. Clin. Oncol. 16(6), 482-488 (1993).
56. Gressen EL, Werner-Wasik M, Cohn J, Topham A, Curran WJ Jr. Thoracic reirradiation for symptomatic relief after prior radiotherapeutic management for lung cancer. Am. J. Clin. Oncol. 23(2), 160-163 (2000).
57. Okamoto Y, Murakami M, Yoden E et al. Reirradiation for locally recurrent lung cancer previously treated with radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 52(2), 390-396 (2002). (Pubitemid 34170844)
58. Wu KL, Jiang GL, Qian H et al. Three-dimensional conformal radiotherapy for locoregionally recurrent lung carcinoma after external beam irradiation: a prospective Phase I-II clinical trial. Int. J. Radiat. Oncol. Biol. Phys. 57(5), 1345-1350 (2003). (Pubitemid 37443975)
59. Kramer GW, Gans S, Ullmann E, van Meerbeeck JP, Legrand CC, Leer JW. Hypofractionated external beam radiotherapy as retreatment for symptomatic non-small-cell lung carcinoma: an effective treatment? Int. J. Radiat. Oncol. Biol. Phys. 58(5), 1388-1393 (2004). (Pubitemid 38438298)
60. Tada T, Fukuda H, Matsui K et al. Non-small-cell lung cancer: reirradiation for loco-regional relapse previously treated with radiation therapy. Int. J. Clin. Oncol. 10(4), 247-250 (2005). (Pubitemid 41242178)
61. Ebara T, Tanio N, Etoh T, Shichi I, Honda A, Nakajima N. Palliative re-irradiation for in-field recurrence after definitive radiotherapy in patients with primary lung cancer. Anticancer Res. 27(1B), 531-534 (2007). (Pubitemid 46374972)
62. Cetingoz R, Arican-Alicikus Z, Nur-Demiral A, Durmak-Isman B, Bakis-Altas B, Kinay M. Is re-irradiation effective in symptomatic local recurrence of non small cell lung cancer patients? A single institution experience and review of the literature. J. BUON 14(1), 33-40 (2009).
63. Timmerman R, Galvin J, Michalski J et al. Accreditation and quality assurance for Radiation Therapy Oncology Group: Multicenter clinical trials using stereotactic body radiation therapy in lung cancer. Acta Oncol. 45(7), 779-786 (2006). (Pubitemid 44423122)
64. Timmerman RD, Kavanagh BD, Cho LC, Papiez L, Xing L. Stereotactic body radiation therapy in multiple body sites. J. Clin. Oncol. 25(8), 947-952 (2007). (Pubitemid 350002860)
65. Pignon JP, Ariagada R, Ihde DC et al. A meta-analysis of thoracic radiotherapy for small cell lung cancer. N. Engl. J. Med. 327(23), 1618-1624 (1992).
66. Kepka L, Sprawka A, Casas F, Abdel- Wahab S, Agarwal JP, Jeremic B. Radiochemotherapy in small-cell lung cancer. Expert Rev. Anticancer Ther. 9(10), 1379-1387 (2009).
67. Ardizzoni A, Hansen H, Dombernowsky P et al. Topotecan, a new active drug in the second-line treatment of small-cell lung cancer: a Phase II study in patients with refractory and sensitive disease. The European Organization for Research and Treatment of Cancer Early Clinical Studies Group and New Drug Development Office, and the Lung Cancer Cooperative Group. J. Clin. Oncol. 15(5), 2090-2096 (1997).
68. Jeremic B, Shibamoto Y, Acimovic L, Milisavljevic S. Carboplatin, etoposide, and accelerated hyperfractionated radiotherapy for elderly patients with limited small cell lung carcinoma: a Phase II study. Cancer 82(5), 836-841 (1998). (Pubitemid 28104161)
69. Murray N, Grafton C, Shah A et al. Abbreviated treatment for elderly, infirm, or noncompliant patients with limited-stage small-cell lung cancer. J. Clin. Oncol. 16(10), 3323-3328 (1998). (Pubitemid 28481628)